The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky (PATH)
Neonatal Abstinence Syndrome
About this trial
This is an interventional treatment trial for Neonatal Abstinence Syndrome
Eligibility Criteria
Inclusion Criteria:
- Pregnant women at 6 to 32 weeks' gestational age
- History of Opioid Use Disorder
- Receiving Medication Assisted Therapy (buprenorphine products or methadone)
- Obtaining prenatal care at one of eleven study sites located throughout Central and Eastern Kentucky
Exclusion Criteria:
-
Sites / Locations
- Karen's Place Maternity CenterRecruiting
- The Medical CenterRecruiting
- Grace Health Women's CareRecruiting
- University of Kentucky Women's Health OB-GYNRecruiting
- Primary Care Centers of Eastern KentuckyRecruiting
- OB/GYN & Women's Health University of LouisvilleRecruiting
- ARH Women's and Family Health Center - MiddlesboroRecruiting
- University of Kentucky Morehead Women's HealthcareRecruiting
- Frontier Behavioral Health CentersRecruiting
- ARH Women's and Family Health Center - Tug ValleyRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Telemedicine Education
Group Care Education
This is a stratified cluster randomized controlled trial with randomization of participating clusters into a 'telemedicine' or 'group care' arm. Sites will be stratified into 'high volume' (>500 deliveries/year) and 'low volume' (<500 deliveries per year). Randomization will be within each strata. Patients attending sites randomized to telemedicine will be recruited by research staff.
This is a stratified cluster randomized controlled trial with randomization of participating clusters into a 'telemedicine' or 'group care' arm. Sites will be stratified into 'high volume' (>500 deliveries/year) and 'low volume' (<500 deliveries per year). Randomization will be within each strata. Patients attending sites randomized to group care will be recruited by research staff.